Crosspoint Capital Strategies, LLC Puma Biotechnology, Inc. Transaction History

Crosspoint Capital Strategies, LLC

  • $50.4 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$59.7 - $99.25 $2.11 Million - $3.51 Million
-35,349 Closed
0 $0
Q4 2017

Feb 13, 2018
SELL
$93.85 - $132.45 $41,200 - $58,145
-439 Reduced 1.23%
35,349 $34.9 Million
Q3 2017

Nov 06, 2017
BUY
$72.0 - $119.75 $2.58 Million - $4.29 Million
35,788
35,788 $4.29 Million

Others Institutions Holding PBYI

# of Institutions
102
Shares Held
29.1M
Call Options Held
60.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $132M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Crosspoint Capital Strategies, LLC Portfolio

Follow Crosspoint Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crosspoint Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crosspoint Capital Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email